These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34804741)

  • 21. Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study.
    Parkin S; Neale J; Brown C; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
    Int J Drug Policy; 2020 Apr; 79():102751. PubMed ID: 32304981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrauterine growth restriction increases morbidity and mortality among premature neonates.
    Garite TJ; Clark R; Thorp JA
    Am J Obstet Gynecol; 2004 Aug; 191(2):481-7. PubMed ID: 15343225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of intrauterine growth restriction among HIV-infected pregnant women: a cohort study.
    López M; Palacio M; Goncé A; Hernàndez S; Barranco FJ; García L; Loncà M; Coll JO; Gratacós E; Figueras F
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):223-30. PubMed ID: 25107626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.
    Kim HK; Nelson LS
    Expert Opin Drug Saf; 2015 Jul; 14(7):1137-46. PubMed ID: 25865597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone for narcotic-exposed newborn infants.
    McGuire W; Fowlie PW
    Cochrane Database Syst Rev; 2002; (4):CD003483. PubMed ID: 12519598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute detoxification of opioid-addicted patients with naloxone during propofol or methohexital anesthesia: a comparison of withdrawal symptoms, neuroendocrine, metabolic, and cardiovascular patterns.
    Kienbaum P; Scherbaum N; Thürauf N; Michel MC; Gastpar M; Peters J
    Crit Care Med; 2000 Apr; 28(4):969-76. PubMed ID: 10809268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
    Zamani N; Hassanian-Moghaddam H
    Ann Emerg Med; 2017 Jun; 69(6):737-739. PubMed ID: 28237362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antinociceptive effects of intravenous administration of three doses of butorphanol tartrate or naloxone hydrochloride following hydromorphone hydrochloride to healthy conscious cats.
    Simon BT; Scallan EM; Baetge CL; Coursey CD; Lizarraga I
    Vet Anaesth Analg; 2019 Jul; 46(4):538-547. PubMed ID: 31171446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.
    McCormick Z; Chu SK; Chang-Chien GC; Joseph P
    Pain Med; 2013 Aug; 14(8):1187-91. PubMed ID: 23647815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit.
    Tofil NM; Benner KW; Faro SJ; Winkler MK
    Pediatr Crit Care Med; 2006 May; 7(3):252-4. PubMed ID: 16575353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enablers and barriers for enteral feeding with mother`s own milk in preterm very low birth weight infants in a tertiary care neonatal intensive care unit.
    Kulkarni D; Murki S; Pawale D; Jena S; Sharma D; Vardhelli V; Kallem V; Bashir T; Naik V; Kiran S
    Turk J Pediatr; 2021; 63(4):564-574. PubMed ID: 34449138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
    Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
    Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of naloxone for reversal of life-threatening opioid toxicity in cancer-related pain.
    Howlett C; Gonzalez R; Yerram P; Faley B
    J Oncol Pharm Pract; 2016 Feb; 22(1):114-20. PubMed ID: 25227231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
    Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK
    Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory depression by tramadol in the cat: involvement of opioid receptors.
    Teppema LJ; Nieuwenhuijs D; Olievier CN; Dahan A
    Anesthesiology; 2003 Feb; 98(2):420-7. PubMed ID: 12552202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of continuous Kangaroo Mother Care initiated immediately after birth (iKMC) on survival of newborns with birth weight between 1.0 to < 1.8 kg: study protocol for a randomized controlled trial.
    WHO Immediate KMC Study Group
    Trials; 2020 Mar; 21(1):280. PubMed ID: 32188485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of naloxone use in hospitalized patients.
    Yung L; Lee KC; Hsu C; Furnish T; Atayee RS
    Postgrad Med; 2017 Jan; 129(1):40-45. PubMed ID: 27858510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk predictors of opioid-induced critical respiratory events in children: naloxone use as a quality measure of opioid safety.
    Chidambaran V; Olbrecht V; Hossain M; Sadhasivam S; Rose J; Meyer MJ
    Pain Med; 2014 Dec; 15(12):2139-49. PubMed ID: 25319840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.